Approval · Notice of Compliance 33444 · 2024
CATHFLO: Notice of Compliance 33444
Issued June 11, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33444
- Date
- June 11, 2024
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternative drug substance manufacturing facility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CATHFLO | Not yet assigned | — |
Medicinal ingredients
- ALTEPLASE 2 MG per VIAL